Evidence map›Paper›PMID 38180357›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2024

Unveiling an Association between Waterpipe Smoking and Bladder Cancer Risk: A Multicenter Case-Control Study in Iran.

Maryam Hadji, Hamideh Rashidian, Maryam Marzban, Abbas Rezaianzadeh, Alireza Ansari-Moghaddam, Mahdieh Bakhshi, Azim Nejatizadeh, Monireh Sadat Seyyedsalehi, Ahmad Naghibzadeh-Tahami, AliAkbar Haghdoost and 9 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 15 institutions in 5 countries.

Maryam HadjiHealth Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.ORCID 0000-0001-5486-7513
Hamideh RashidianCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-2155-1683
Maryam MarzbanDepartment of Public Health, School of Public Health, Bushehr University of Medical Science, Bushehr, Iran.ORCID 0000-0001-6703-2224
Abbas RezaianzadehColorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0002-0067-0659
Alireza Ansari-MoghaddamHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.ORCID 0000-0002-3267-7193
Mahdieh BakhshiHealth Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.ORCID 0000-0001-6138-0009
Azim NejatizadehTobacco and Health Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.ORCID 0000-0001-6347-0163
Monireh Sadat SeyyedsalehiCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9063-9128
Ahmad Naghibzadeh-TahamiSocial Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.ORCID 0000-0002-2221-7302
AliAkbar HaghdoostDepartment of Biostatistics and Epidemiology, Kerman University of Medical Sciences, Kerman, Iran.ORCID 0000-0003-4628-4849
Elham MohebbiCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0868-4067
Neal D FreedmanMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.ORCID 0000-0003-0074-1098
Reza MalekzadehLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9820-6335
Arash EtemadiMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.ORCID 0000-0002-3458-1072
Farin KamangarDepartment of Biology, School of Computer, Mathematical and Natural Sciences, Morgan State University, Baltimore, Maryland.ORCID 0000-0003-4169-7978
Elisabete WeiderpassInternational Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-2237-0128
Eero PukkalaHealth Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.ORCID 0000-0001-9536-6440
Paolo BoffettaDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.ORCID 0000-0002-3811-2791
Kazem ZendehdelCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-0269-4945
Kerman University of Medical Sciences · IRMotamed Cancer Institute · IRShariati Hospital · IRZahedan University of Medical Sciences · IRBushehr University of Medical Sciences · IRCentre international de recherche sur le cancer · FRFinnish Cancer Registry · FIGeorgetown University · USHormozgan University of Medical Sciences · IRIran University of Medical Sciences · IRMorgan State University · USNational Cancer Institute · USShiraz University of Medical Sciences · IRStony Brook University · USTampere University · FI

Funding

Upper Gastrointestinal Cancer StudiesZIACP000185 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$25.6M
World Health Organization 001
6 · The paper itself

Abstract

backgroundLimited data exist for the association between bladder cancers and waterpipe smoking, an emerging global public health concern.

methodsWe used the IROPICAN database in Iran and used multivariable logistic regression, adjusting for cigarette smoking, opium use, and other confounding factors. In addition, we studied the association between exclusive waterpipe smoking and bladder cancer.

resultsWe analyzed 717 cases and 3,477 controls and a subset of 215 patients and 2,145 controls who did not use opium or cigarettes. Although the OR adjusted for opium, cigarettes, and other tobacco products was 0.92 [95% confidence interval (CI), 0.69-1.20], we observed a statistically significant elevated risk in exclusive waterpipe smokers (OR = 1.78; 95% CI, 1.16-2.72) compared with non-users of opium or any tobacco. Associations were strongest for smoking more than two heads/day (OR = 2.25; 95% CI, 1.21-4.18) and for initiating waterpipe smoking at an age less than 20 (OR = 2.73; 95% CI, 1.11-6.72). The OR for urothelial bladder cancer was higher in ex-smokers (OR = 2.35; 95% CI, 1.24-4.42) than in current smokers (OR = 1.52; 95% CI, 0.72-3.15). All observed associations were consistently higher for urothelial histology.

conclusionsWaterpipe smoking may be associated with an increased risk of bladder cancer, notably among individuals who are not exposed to cigarette smoking and opium. IMPACT: The study provides compelling evidence that waterpipe smoking is a confirmed human carcinogen, demanding action from policymakers. See related In the Spotlight, p. 461.

Indexed as

Urinary Bladder NeoplasmsWater Pipe SmokingCase-Control StudiesHumansIranNicotianaOpiumOpium

Identifiers

PMID38180357
PMCPMC10988205
OpenAlexW4390617238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.